As of Oct 20
| +1.10 / +14.67%|
The 4 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 25.50, with a high estimate of 30.00 and a low estimate of 22.00. The median estimate represents a +196.51% increase from the last price of 8.60.
The current consensus among 4 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.